Alfred R. Rudolph

Alfred R.
Rudolph, M.D.
has served as Chief Operating Officer since 1998.
In July 2004, Dr. Rudolph and Mr. Waldron were appointed jointly to the Office of the President.
Dr. Rudolph has over 30 years of experience in the biopharmaceutical industry.
Since joining us in April 1997, Dr. Rudolph has been responsible for the clinical, research, regulatory, manufacturing, and quality assurance functions of our Company.
Before joining us, Dr. Rudolph was President and Chief Operating Officer of Neptune Pharmaceuticals, Inc., a marine-based natural product screening company.
Previously, Dr. Rudolph was Senior Vice President of T Cell Sciences, Inc., Director of Clinical Operations at Cetus Corporation, and Clinical Assistant Professor of Medicine at University of California, San Francisco.
He began his pharmaceutical career with Bristol Myers, where he worked in cancer drug development.
Dr. Rudolph earned a B.S.
in Electrical Engineering from the University of Rochester, and completed his medical training in Hemotology-Oncology at Syracuse University.